Analgesic properties of S100A9 C-terminal domain: A mechanism dependent on calcium channel inhibition

Fundamental and Clinical Pharmacology

Volumn 23, Issue 4, 2009, Pages 427-438

  Dale, Camila Squarzoni ^a,b   Altier, Christophe ^c   Cenac, Nicolas ^a,b   Giorgi, Renata ^d   Juliano, Maria Aparecida ^e   Juliano, Luiz ^e   Zamponi, Gerald W ^c   Vergnolle, Nathalie ^a,b,f  

^a INSERM   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c UNIVERSITY OF CALGARY   (Canada)

^d INSTITUTO BUTANTAN   (Brazil)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^f UNIVERSITY OF CALGARY   (Canada)

Author keywords

Antinociception; Dorsal root ganglia neurons; Inflammation; N type calcium channels; S100A9; Voltage operated calcium channels

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CALGRANULIN B; CARRAGEENAN; FORMALDEHYDE; MS100A9P PROTEIN; MYELOPEROXIDASE; OPIATE RECEPTOR; POTASSIUM CHLORIDE; UNCLASSIFIED DRUG;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL INFILTRATION; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSFECTION; GRANULOCYTE; HEAT; HUMAN; HUMAN CELL; HYPERALGESIA; IN VIVO CULTURE; MALE; MOUSE; NERVE CELL; NOCICEPTION; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SPINAL GANGLION;

ANALGESICS; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, N-TYPE; CALCIUM SIGNALING; CALGRANULIN B; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; PAIN; PAIN MEASUREMENT; TRANSFECTION;

EID: 68749091409     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2009.00686.x     Document Type: Article

References (44)

1. Hessian P.A., Edgeworth J., Hogg N. MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes. J. Leukoc. Biol. (1993) 53 197 204.
2. Roth J., Vogl T., Sunderkotter C., Sorg C. Chemotactic activity of S100A8 and S100A9. J. Immunol. (2003) 171 5651.
3. Raftery M.J., Harrison C.A., Alewood P., Jones A., Geczy C.L. Isolation of the murine S100 protein MRP14 (14 kDa migration-inhibitory-factor-related protein) from activated spleen cells: characterization of post-translational modifications and zinc binding. Biochem. J. (1996) 316 285 293.
4. Kerkhoff C., Klempt M., Kaever V., Sorg C. The two calcium-binding proteins, S100A8 and S100A9, are involved in the metabolism of arachidonic acid in human neutrophils. J. Biol. Chem. (1999) 274 32672 32679.
5. Kerkhoff C., Klempt M., Sorg C. Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochim. Biophys. Acta. (1998) 1448 200 211.
6. Giorgi R., Pagano R.L., Dias M.A., Aguiar-Passeti T., Sorg C., Mariano M. Antinociceptive effect of the calcium-binding protein MRP-14 and the role played by neutrophils on the control of inflammatory pain. J. Leukoc. Biol. (1998) 64 214 220.
7. Pagano R.L., Dias M.A., Dale C.S., Giorgi R. Neutrophils and the calcium-binding protein MRP-14 mediate carrageenan-induced antinociception in mice. Mediators Inflamm. (2002) 11 203 210.
8. Pagano R.L., Mariano M., Giorgi R. Neutrophilic cell-free exudate induces antinociception mediate by the protein S100A9. Mediators Inflamm. (2006) 2006, 36765.
9. Pagano R.L., Sampaio S.C., Juliano L., Juliano M.A., Giorgi R. The C-terminus of murine S100A9 inhibits spreading and phagocytic activity of adherent peritoneal cells. Inflamm. Res. (2005) 54 204 210.
10. Dale C.S., Pagano R.L., Paccola C.C. et al. Effect of the C-terminus of murine S100A9 protein on experimental nociception. Peptides (2006) 27 2794 2802.
11. Dale C.S., Goncalves L.R.C., Juliano L., Juliano M.A., da Silva A.M., Giorgi R. The C-terminus of murine S100A9 inhibits hyperalgesia and edema induced by jararhagin. Peptides (2004) 25 81 89.
12. Dale C.S., Cenac N., Britto L.R. et al. The C-terminus of murine S100A9 protein inhibits hyperalgesia induced by the agonist peptide of protease-activated receptor 2 (PAR2). Br. J. Pharmacol. (2006) 149 374 384.
13. Loomans H.J., Hahn B.L., Li Q.Q., Phadnis S.H., Sohnle P.G. Histidine-based zinc-binding sequences and the antimicrobial activity of calprotectin. J. Infect. Dis. (1998) 177 812 814.
14. Sopalla C., Leukert N., Sorg C., Kerkhoff C. Evidence for the involvement of the unique C-tail of S100A9 in the binding of arachidonic acid to the heterocomplex S100A8/A9. Biol. Chem. (2002) 383 1895 1905.
15. Watt K.W., Brightman I.L., Goetzl E.J. Isolation of two polypeptides comprising the neutrophil-immobilizing factor of human leucocytes. Immunology (1983) 48 79 86.
16. Freemont P., Hogg N., Edgeworth J. Sequence identity. Nature (1989) 339 516.
17. Hessian P.A., Wilkinson L., Hogg N. The S100 family protein MRP-14 (S100A9) has homology with the contact domain of high molecular weight kininogen. FEBS Lett. (1995) 371 271 275.
18. Juni A., Klein G., Kest B. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems. Brain Res. (2006) 1070 35 44.
19. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain (1988) 32 77 88.
20. Takasaki I., Andoh T., Nojima H., Shiraki K., Kuraishi Y. Gabapentin antinociception in mice with acute herpetic pain induced by herpes simplex virus infection. J. Pharmacol. Exp. Ther. (2001) 296 270 275.
21. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain (1983) 6 109 110.
22. Bradley P.P., Priebat D.A., Christensen R.D., Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. (1982) 78 206 209.
23. 2)-activating peptides in the rat paw. Br. J. Pharmacol. (1999) 127 1083 1090.
24. Asfaha S., Cenac N., Houle S. et al. Protease-activated receptor-4: a novel mechanism of inflammatory pain modulation. Br. J. Pharmacol. (2007) 150 176 185.
25. Cenac N., Andrews C., Holzhausen M. et al. Proteases are released in Irritable Bowel Syndrome: a role in visceral pain. J. Clin. Invest. (2007) 117, 636 647.
26. Beedle A.M., McRory J.E., Poirot O. et al. Agonist-independent modulation of N-type calcium channels by ORL1 receptors. Nat. Neurosci. (2004) 7 118 125.
27. Vanderah T.W. Pathophysiology of pain. Med. Clin. North Am. (2007) 91 1 12.
28. Thastrup O., Cullen P.J., Drobak B.K., Hanley M.R., Dawson A.P. Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. Proc. Natl Acad. Sci. USA (1990) 87 2466 2470.
29. Luckasen J.R., White J.G., Kersey J.H. Mitogenic properties of a calcium ionophore, A23187. Proc. Natl. Acad. Sci. USA (1974) 71 5088 5090.
30. Prado W.A. Involvement of calcium in pain and antinociception. Braz. J. Med. Biol. Res. (2001) 34 449 461.
31. Lee Y., Lee C.H., Oh U. Painful channels in sensory neurons. Mol. Cells. (2005) 20 315 324.
32. Sutton K.G., Martin D.J., Pinnock R.D., Lee K., Scott R.H. Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurons. Br. J. Pharmacol. (2002) 135 257 265.
33. Altier C., Khosravani H., Evans R.M. et al. ORL1 receptor-mediated internalization of N-type calcium channels. Nat. Neurosci. (2006) 9 31 40.
34. Parada C.A., Tambeli C.H., Cunha F.Q., Ferreira S.H. The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception. Neuroscience (2001) 102 937 944.
35. Dray A., Bevan S. Inflammation and hyperalgesia: highlighting the team effort. Trends Pharmacol. Sci. (1993) 14 287 290.
36. Striz I., Trebichavsky I. Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiol. Res. (2004) 53 245 253.
37. Zamponi G.W., Snutch T.P. Modulation of voltage-dependent calcium channels by G proteins. Curr. Opin. Neurobiol. (1998) 8 351 356.
38. Vanegas H., Schaible H. Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia. Pain (2000) 85 9 18.
39. Nelson M.T., Joksovic P.M., Su P. et al. Molecular mechanisms of subtype-specific inhibition of neuronal T-type calcium channels by ascorbate. J. Neurosci. (2007) 27 12577 12583.
40. Gribkoff V.K. The role of voltage-gated calcium channels in pain and nociception. Semin. Cell Dev. Biol. (2006) 17 555 564.
41. Maggi C.A., Tramontana M., Cecconi R., Santicioli P. Neurochemical evidence for the involvement of N-type calcium channels in transmitter secretion from peripheral endings of sensory nerves in guinea pigs. Neurosci. Lett. (1990) 114 203 206.
42. Santicioli P., Del Bianco E., Tramontana M., Geppetti P., Maggi C.A. Release of calcitonin gene-related peptide like-immunoreactivity induced by electrical field stimulation from rat spinal afferents is mediated by conotoxin-sensitive calcium channels. Neurosci. Lett. (1992) 136 161 164.
43. Smith M.T., Cabot P.J., Ross F.B., Robertson A.D., Lewis R.J. The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices. Pain (2002) 96 119 127.
44. Altier C., Dale C.S., Kisilevsky A.E. et al. Differential role of N-type calcium channel splice isoforms in pain. J. Neurosci. (2007) 27 6363 6373.